PULM
Price
$2.60
Change
-$2.19 (-45.72%)
Updated
Feb 3 closing price
Capitalization
9.5M
50 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$1.49
Change
-$2.34 (-61.10%)
Updated
Feb 3 closing price
Capitalization
93.4M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PULM vs PYXS

Header iconPULM vs PYXS Comparison
Open Charts PULM vs PYXSBanner chart's image
Pulmatrix
Price$2.60
Change-$2.19 (-45.72%)
Volume$13.59K
Capitalization9.5M
Pyxis Oncology
Price$1.49
Change-$2.34 (-61.10%)
Volume$1.36M
Capitalization93.4M
PULM vs PYXS Comparison Chart in %
PULM
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PULM vs. PYXS commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PULM is a StrongBuy and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (PULM: $2.60 vs. PYXS: $1.49)
Brand notoriety: PULM and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PULM: 59% vs. PYXS: 89%
Market capitalization -- PULM: $9.5M vs. PYXS: $93.4M
PULM [@Biotechnology] is valued at $9.5M. PYXS’s [@Biotechnology] market capitalization is $93.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PULM’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • PULM’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than PULM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PULM’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • PULM’s TA Score: 4 bullish, 3 bearish.
  • PYXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PULM is a better buy in the short-term than PYXS.

Price Growth

PULM (@Biotechnology) experienced а -0.23% price change this week, while PYXS (@Biotechnology) price change was -9.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

PULM is expected to report earnings on Mar 26, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($93.4M) has a higher market cap than PULM($9.5M). PYXS YTD gains are higher at: 29.565 vs. PULM (16.592). PULM has higher annual earnings (EBITDA): -6.21M vs. PYXS (-83.07M). PYXS has more cash in the bank: 76.3M vs. PULM (4.79M). PULM has less debt than PYXS: PULM (0) vs PYXS (19.1M). PYXS has higher revenues than PULM: PYXS (2.82M) vs PULM (3K).
PULMPYXSPULM / PYXS
Capitalization9.5M93.4M10%
EBITDA-6.21M-83.07M7%
Gain YTD16.59229.56556%
P/E RatioN/AN/A-
Revenue3K2.82M0%
Total Cash4.79M76.3M6%
Total Debt019.1M-
FUNDAMENTALS RATINGS
PULM: Fundamental Ratings
PULM
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PULMPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
PULM
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMST1.950.15
+8.33%
Amesite
AVNT37.400.85
+2.33%
Avient Corp
WSR14.39-0.05
-0.35%
Whitestone REIT
TPR127.03-2.64
-2.04%
Tapestry
FGBI8.87-0.39
-4.21%
First Guaranty Bancshares

PULM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
+0.39%
ORMP - PULM
33%
Loosely correlated
+0.29%
INM - PULM
30%
Poorly correlated
-3.64%
GERN - PULM
27%
Poorly correlated
-1.95%
GYRE - PULM
27%
Poorly correlated
-3.53%
PYXS - PULM
26%
Poorly correlated
-2.61%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-2.61%
KURA - PYXS
60%
Loosely correlated
-0.48%
CABA - PYXS
46%
Loosely correlated
+3.60%
BEAM - PYXS
43%
Loosely correlated
-0.11%
HOWL - PYXS
41%
Loosely correlated
-2.42%
SYRE - PYXS
40%
Loosely correlated
+1.65%
More